Shares in biopharmaceutical group Outlook Therapeutics ($OTLK) collapsed in pre-market trading after the U.S. Food and Drug ...

The use of vascular endothelial growth factor (VEGF) inhibitors, particularly anti-VEGF agents like Bevacizumab, has become a cornerstone in the treatment of proliferative diabetic retinopathy and ...

Intravitreal injections (IVIs) are the most common outpatient procedure worldwide, yet no consensus exists regarding their optimal setting. This study analysed 101 976 IVIs performed between 2017 and ...

According to Aldeyra Therapeutics, a phase 2/3 trial of ADX-2191 in patients with retinitis pigmentosa is expected to begin in 2025. The Food and Drug Administration (FDA) has granted Fast Track ...

The role of anesthetics in streamlining efficiency and elevating patient care. An aging population combined with the increasing incidence of chronic disease has led to a steady rise in the number of ...

Dr. Amit Gupta, MD, FACS, Ophthalmologist, talks about safety and the low risks associated with intravitreal injections. Mike Johnson Shifts Tone On Health Care As Shutdown Drags On Tim Curry’s wry ...

The role of compounded anesthetic formulations in streamlining efficiency and elevating patient care. Intravitreal injections often feel overwhelming for patients and time-consuming for clinics. From ...

Please provide your email address to receive an email when new articles are posted on . There are more options available than just the standard methods. Choices need to be made for every step of the ...

The current standards of care involve using anti-VEGF agents, which selectively target extracellular VEGF. We've been doing this for years and those drugs do a good job, but there are limitations ...

WEDNESDAY, Oct. 23, 2024 (HealthDay News) -- A history of multiple past intravitreal injections (IVIs) poses a risk for certain future cataract surgery complications, according to a study presented at ...